At this time, posts about Myeongmun Pharmaceutical are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net sold 17,000 shares today. Myeongmun Pharmaceutical is known as a comprehensive pharmaceutical company focusing on prescription drugs.

As of 11:30 AM on the 25th, Myeongmun Pharmaceutical's stock price is 6,930 KRW, up 8.11% from the previous day, with a trading volume of 16,554,457 shares, which is 67.43% of the 5-day average trading volume. On May 18, Myeongmun Pharmaceutical became a market issue with the headline "Turning to an upward trend despite operating losses... Expectations for COVID-19 treatment."

In addition to Myeongmun Pharmaceutical, posts by investors are also rapidly increasing for AfreecaTV (067160), Samsung Heavy Industries (010140), and Wemade (112040).

※Source: AI Investment Assistant AI Rassi-ro

※ This article was written in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing